<DOC>
	<DOCNO>NCT01415726</DOCNO>
	<brief_summary>Type 2 diabetes common form diabetes . The prevalence diabetes markedly increase recent year . More child young adult develop devastate disease . Despite multiple factor ( e.g. , food , environmental , genetic factor ) contribute develop diabetes , increase evidence demonstrate chronic inflammation and/or atuoimmunity common issue play key role pathogenesis type 2 diabetes , lead insulin resistance shortage insulin-producing islet beta cell . Thus , anti-inflammation become novel approach treatment type 2 diabetes . Evidence multipotent stem cell derive human cord blood ( CB-SCs ) control inflammation autoimmune response alter regulatory T cell ( Tregs ) human islet beta cell-specific T cell clone type 1 diabetes offer promise new approach treat type 2 diabetes . Here , investigator develop novel Stem Cell Educator therapy use CB-SC explore therapeutic effectiveness Stem Cell Educator therapy T2D patient .</brief_summary>
	<brief_title>Stem Cell Educator Therapy Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patients screen enrollment study clinical sign laboratory test meet diagnosis standard American Diabetes Association 2010 . Other key inclusion criterion presence least one autoantibody pancreatic islet Î² cell autoimmunerelated type 2 diabetes . Exclusion criterion clinically significant disease liver , kidney , heart . Additional exclusion criterion pregnancy , immunosuppressive medication , viral disease disease associated immunodeficiency .</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Cord blood stem cell</keyword>
	<keyword>inflammation</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>stem cell educator</keyword>
	<keyword>autoimmunity</keyword>
	<keyword>immune modulation</keyword>
</DOC>